1Department of Neurosurgery, Warren Alpert Medical School of Brown University, Providence, Rhode Island.
2Center for Skull Base and Pituitary Surgery, Neurological Institute of New Jersey, Newark, New Jersey.
Neurosurg Focus. 2022 Jul;53(1):E14. doi: 10.3171/2022.4.FOCUS2285.
Patient frailty is associated with poorer perioperative outcomes for several neurosurgical procedures. However, comparative accuracy between different frailty metrics for cerebral arteriovenous malformation (AVM) outcomes is poorly understood and existing frailty metrics studied in the literature are constrained by poor specificity to neurosurgery. This aim of this paper was to compare the predictive ability of 3 frailty scores for AVM microsurgical admissions and generate a custom risk stratification score.
All adult AVM microsurgical admissions in the National (Nationwide) Inpatient Sample (2002-2017) were identified. Three frailty measures were analyzed: 5-factor modified frailty index (mFI-5; range 0-5), 11-factor modified frailty index (mFI-11; range 0-11), and Charlson Comorbidity Index (CCI) (range 0-29). Receiver operating characteristic curves were used to compare accuracy between metrics. The analyzed endpoints included in-hospital mortality, routine discharge, complications, length of stay (LOS), and hospitalization costs. Survey-weighted multivariate regression assessed frailty-outcome associations, adjusting for 13 confounders, including patient demographics, hospital characteristics, rupture status, hydrocephalus, epilepsy, and treatment modality. Subsequently, k-fold cross-validation and Akaike information criterion-based model selection were used to generate a custom 5-variable risk stratification score called the AVM-5. This score was validated in the main study population and a pseudoprospective cohort (2018-2019).
The authors analyzed 16,271 total AVM microsurgical admissions nationwide, with 21.0% being ruptured. The mFI-5, mFI-11, and CCI were all predictive of lower rates of routine discharge disposition, increased perioperative complications, and longer LOS (all p < 0.001). Their AVM-5 risk stratification score was calculated from 5 variables: age, hydrocephalus, paralysis, diabetes, and hypertension. The AVM-5 was predictive of decreased rates of routine hospital discharge (OR 0.26, p < 0.001) and increased perioperative complications (OR 2.42, p < 0.001), postoperative LOS (+49%, p < 0.001), total LOS (+47%, p < 0.001), and hospitalization costs (+22%, p < 0.001). This score outperformed age, mFI-5, mFI-11, and CCI for both ruptured and unruptured AVMs (area under the curve [AUC] 0.78, all p < 0.001). In a pseudoprospective cohort of 2005 admissions from 2018 to 2019, the AVM-5 remained significantly associated with all outcomes except for mortality and exhibited higher accuracy than all 3 earlier scores (AUC 0.79, all p < 0.001).
Patient frailty is predictive of poorer disposition and elevated complications, LOS, and costs for AVM microsurgical admissions. The authors' custom AVM-5 risk score outperformed age, mFI-5, mFI-11, and CCI while using threefold less variables than the CCI. This score may complement existing AVM grading scales for optimization of surgical candidates and identification of patients at risk of postoperative medical and surgical morbidity.
患者衰弱与多种神经外科手术的围手术期结局较差相关。然而,不同衰弱指标在脑动静脉畸形(AVM)结局方面的比较准确性尚未得到充分理解,并且文献中研究的现有衰弱指标受到神经外科特异性差的限制。本文旨在比较 3 种衰弱评分对 AVM 显微手术入院的预测能力,并生成一个定制的风险分层评分。
在全国(全国范围)住院患者样本(2002-2017 年)中确定所有成人 AVM 显微手术入院患者。分析了 3 种衰弱指标:5 因素改良衰弱指数(mFI-5;范围 0-5)、11 因素改良衰弱指数(mFI-11;范围 0-11)和 Charlson 合并症指数(CCI;范围 0-29)。使用接收者操作特征曲线比较指标之间的准确性。分析的终点包括院内死亡率、常规出院、并发症、住院时间(LOS)和住院费用。加权多元回归评估衰弱与结局的关联,调整了 13 个混杂因素,包括患者人口统计学、医院特征、破裂状态、脑积水、癫痫和治疗方式。随后,使用 k 折交叉验证和基于 Akaike 信息准则的模型选择生成一个名为 AVM-5 的定制 5 变量风险分层评分。该评分在主要研究人群和一个伪前瞻性队列(2018-2019 年)中进行了验证。
作者分析了全国范围内 16271 例 AVM 显微手术入院患者,其中 21.0%为破裂。mFI-5、mFI-11 和 CCI 均预测常规出院处置率较低、围手术期并发症增加和 LOS 延长(均 p < 0.001)。他们的 AVM-5 风险分层评分是根据 5 个变量计算的:年龄、脑积水、瘫痪、糖尿病和高血压。AVM-5 预测常规医院出院率降低(OR 0.26,p < 0.001)和围手术期并发症增加(OR 2.42,p < 0.001),术后 LOS 延长(+49%,p < 0.001),总 LOS 延长(+47%,p < 0.001)和住院费用增加(+22%,p < 0.001)。该评分在破裂和未破裂的 AVM 中均优于年龄、mFI-5、mFI-11 和 CCI(曲线下面积 [AUC] 0.78,均 p < 0.001)。在 2018 年至 2019 年期间 2005 例入院的伪前瞻性队列中,AVM-5 仍然与所有结局显著相关,除了死亡率,并且比所有 3 个早期评分表现出更高的准确性(AUC 0.79,均 p < 0.001)。
患者衰弱与 AVM 显微手术入院的较差处置和并发症增加、LOS 和费用相关。作者的自定义 AVM-5 风险评分优于年龄、mFI-5、mFI-11 和 CCI,同时使用的变量比 CCI 少三倍。该评分可补充现有的 AVM 分级量表,以优化手术候选人和识别术后医疗和手术发病率风险的患者。